Trademark: 97079718
Word
NATIVE GENE THERAPY
Status
Dead
Status Code
602
Status Date
Thursday, June 15, 2023
Serial Number
97079718
Mark Type
4000
Filing Date
Monday, October 18, 2021
Abandoned Date
Friday, June 2, 2023

Trademark Owner History

Classifications
5 Pharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease
"GENE THERAPY"

Trademark Events
Jun 15, 2023
Abandonment Notice E-Mailed - Failure To Respond
Jun 15, 2023
Abandonment Notice Mailed - Failure To Respond
Jun 15, 2023
Abandonment - Failure To Respond Or Late Response
Dec 1, 2022
Notification Of Final Refusal Emailed
Dec 1, 2022
Final Refusal E-Mailed
Dec 1, 2022
Final Refusal Written
Oct 18, 2022
Teas/Email Correspondence Entered
Oct 17, 2022
Correspondence Received In Law Office
Oct 17, 2022
Teas Response To Office Action Received
Apr 17, 2022
Notification Of Non-Final Action E-Mailed
Apr 17, 2022
Non-Final Action E-Mailed
Apr 17, 2022
Non-Final Action Written
Mar 8, 2022
Teas/Email Correspondence Entered
Mar 7, 2022
Correspondence Received In Law Office
Mar 7, 2022
Teas Response To Office Action Received
Dec 22, 2021
Notification Of Non-Final Action E-Mailed
Dec 22, 2021
Non-Final Action E-Mailed
Dec 22, 2021
Non-Final Action Written
Dec 13, 2021
Assigned To Examiner
Nov 4, 2021
New Application Office Supplied Data Entered
Oct 21, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24